1,076 results on '"Pilotti, S."'
Search Results
2. POS1497 PREVALENCE OF SARCOPENIA IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
3. AB0315 ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS APPEAR TO HAVE IMPAIRED QUADRICEPS MUSCLE MORPHOLOGY ASSESSED BY ULTRASOUND AND MUSCLE STRENGTH IMPAIRED OVER TIME: A COHORT STUDY
4. AB0475 TRANSCRANIAL DIRECT CURRENT STIMULATION DECREASES CHRONIC PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RANDOMIZED, CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL
5. AB1820-HPR BIOELECTRICAL IMPEDANCE ANALYSIS SHOWED HIGH AGREEMENT AND SPECIFICITY TO ASSESSMENT OF LOW APPENDICULAR SKELETAL MUSCLE MASS IN WOMEN WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA
6. AB0860 DISEASE ACTIVITY IS ASSOCIATED WITH LOW QUADRICEPS MUSCLE THICKNESS IN WOMEN WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA
7. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
8. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
9. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
10. Supplementary Figure 1 from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
11. Supplementary Figure 3 from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
12. Supplementary Figure 2 from Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
13. Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis
14. AB0173 MORPHOLOGICAL PARAMETERS ASSESSED BY ULTRASOUND IN QUADRICEPS MUSCLE WERE ASSOCIATED WITH CLINICAL FEATURES, MUSCLE STRENGTH, FUNCTIONAL CAPACITY AND PHYSICAL FUNCTION OF RHEUMATOID ARTHRITIS PATIENTS
15. Sunitinib malate in solitary fibrous tumor (SFT)
16. Mode of action of trabectedin in myxoid liposarcomas
17. Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients
18. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect
19. Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
20. Papillomavirus Infection in the Male: Results of a Peniscopic Study
21. Response to imatinib plus sirolimus in advanced chordoma
22. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series
23. PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
24. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
25. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
26. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
27. Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients
28. Effect of imatinib on haematopoietic recovery following idarubicin exposure
29. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis
30. Phase II study on lapatinib in advanced EGFR-positive chordoma†
31. Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
32. Elevated risk for MPNST in NF1 microdeletion patients. (Report)
33. Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
34. Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
35. Myoepithelial tumours of soft tissues and extraskeletal myxoid chondrosarcomas feature a distinct transcriptional pattern
36. Tumor response to sunitinib malate observed in clear-cell sarcoma
37. Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs)
38. Prognostic factors for metachronous contralateral breast cancer: A comparison of the linear Cox regression model and its artificial neural network extension
39. ALT-associated promyelocytic leukaemia body (APB) detection as a reproducible tool to assess alternative lengthening of telomere stability in liposarcomas#
40. Analysis of potential receptor tyrosine kinase targets in intimal and mural sarcomas
41. Overexpression of the C-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium
42. Re: Oda et al. Frequent alteration of p16INK4a/p14ARF and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14ARF expression both correlate with poor prognosis. J Pathol 2005;207:410–421
43. PDGFRα, PDGFRβ and KIT expression/activation in conventional chondrosarcoma
44. Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript
45. Prediction of TP53 Status for Primary Cisplatin, Fluorouracil, and Leucovorin Chemotherapy in Ethmoid Sinus Intestinal-Type Adenocarcinoma
46. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry
47. Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hürthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up
48. PROGNOSTIC RELEVANCE OF HPV AND TP53 GENE STATUS IN SQUAMOUS CELL CANCERS (SCC) OF OROPHARYNX TREATED WITH SURGERY +/− RADIOTHERAPY (RT)
49. ANTI-ANDROGEN THERAPY IN RECURRENT AND/OR METASTATIC SALIVARY GLANDS CARCINOMA (RSGC)
50. Detection of bladder cancer by multitarget multicolour FISH: comparative analysis on archival cytology and paraffin-embedded tissue
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.